Treatment continuation of four long-acting antipsychotic medications in the Netherlands and Belgium: A retrospective database study

• Flore Decuypere ,

  * E-mail: flore.decuypere@quintilesims.com (FD); jsermon@its.jnj.com (JS); pgeerts@its.jnj.com (PG); tdenee@its.jnj.com (TRD); cdevos4@its.jnj.com (CDV); bmalfait@its.jnj.com (BM); mark.lamotte@quintilesims.com (ML)

  Affiliation Commercial Services, QuintilesIMS, Zaventem, Belgium

  http://orcid.org/0000-0003-2083-0880

  ⨯
• Jan Sermon ,

  * E-mail: flore.decuypere@quintilesims.com (FD); jsermon@its.jnj.com (JS); pgeerts@its.jnj.com (PG); tdenee@its.jnj.com (TRD); cdevos4@its.jnj.com (CDV); bmalfait@its.jnj.com (BM); mark.lamotte@quintilesims.com (ML)

  Affiliation Health Economics, Market Access, Reimbursement, Janssen-Cilag NV, Beerse, Belgium

  ⨯
• Paul Geerts ,

  * E-mail: flore.decuypere@quintilesims.com (FD); jsermon@its.jnj.com (JS); pgeerts@its.jnj.com (PG); tdenee@its.jnj.com (TRD); cdevos4@its.jnj.com (CDV); bmalfait@its.jnj.com (BM); mark.lamotte@quintilesims.com (ML)

  Affiliation Medical Affairs, Janssen-Cilag NV, Beerse, Belgium

  ⨯
• Tom R. Denee ,

  * E-mail: flore.decuypere@quintilesims.com (FD); jsermon@its.jnj.com (JS); pgeerts@its.jnj.com (PG); tdenee@its.jnj.com (TRD); cdevos4@its.jnj.com (CDV); bmalfait@its.jnj.com (BM); mark.lamotte@quintilesims.com (ML)

  Affiliation Health Economics, Market Access, Reimbursement, Janssen-Cilag BV, Tilburg, Netherlands

  ⨯
• Cedric De Vos ,

  * E-mail: flore.decuypere@quintilesims.com (FD); jsermon@its.jnj.com (JS); pgeerts@its.jnj.com (PG); tdenee@its.jnj.com (TRD); cdevos4@its.jnj.com (CDV); bmalfait@its.jnj.com (BM); mark.lamotte@quintilesims.com (ML)

  Affiliation Health Economics, Market Access, Reimbursement, Janssen-Cilag NV, Beerse, Belgium

  ⨯
• Bart Malfait ,

  * E-mail: flore.decuypere@quintilesims.com (FD); jsermon@its.jnj.com (JS); pgeerts@its.jnj.com (PG); tdenee@its.jnj.com (TRD); cdevos4@its.jnj.com (CDV); bmalfait@its.jnj.com (BM); mark.lamotte@quintilesims.com (ML)

  Affiliation Health Economics, Market Access, Reimbursement, Janssen-Cilag NV, Beerse, Belgium

  ⨯
• Mark Lamotte ,

  * E-mail: flore.decuypere@quintilesims.com (FD); jsermon@its.jnj.com (JS); pgeerts@its.jnj.com (PG); tdenee@its.jnj.com (TRD); cdevos4@its.jnj.com (CDV); bmalfait@its.jnj.com (BM); mark.lamotte@quintilesims.com (ML)

  Affiliation Real-World Evidence Solutions, QuintilesIMS, Zaventem, Belgium

  ⨯
• Cornelis L. Mulder

  Affiliation Department of Psychiatry, Erasmus MC, Rotterdam, Netherlands

  ⨯